NPHP3

Across TCGA pan-cancer cohorts, NPHP3 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NPHP3 data layer compared with 26 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher NPHP3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated NPHP3 expression acts as an unfavorable survival marker.

CCRCC, LSCC, and UCEC are the cancer types where NPHP3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.516	1.000	.009	17	view →
LSCC	DFS	Quartile	II,III,IV	0.326	1.000	.027	6	view →
UCEC	DFS	Median	All	0.784	0.966	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

NPHP3–CCRCC (OS)

Open the CCRCC breakdown →